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Background: Hypocapnia induced following the accidental intravenous infusion of a local anesthetic can mitigate
anesthetic toxicity, but the effects of hypocapnia induced prior to local anesthetic infusion are unknown. In this
study, we examined the effects of prior hypocapnia on bupivacaine-induced cardiotoxicity in rats.
Methods: Eighteen Sprague–Dawley rats were randomly divided into two groups: one receiving sevoflurane with
normal ventilation (Control Group) and the other receiving sevoflurane with hyperventilation to induce hypocapnia
(Hypocapnia Group). After 30 min, both groups received continuous intravenous infusions of 0.25% bupivacaine at
2 mg · kg−1 · min−1. The time taken to reach 25% and 50% reductions in heart rate (HR; HR-25%, HR-50%) and mean
arterial pressure (MAP; MAP-25%, MAP-50%) from the start of bupivacaine infusion were recorded. The difference
between HR-25% and MAP-25% was calculated. The times of the first ventricular premature beat (VPB) and final
systole were also recorded.
Results: In the Hypocapnia Group, HR-50%, MAP-25%, and MAP-50% were prolonged compared with the Control
Group (P < 0.001). Furthermore, the interval between HR-25% and MAP-25% and the times between the first VPB
and final systole were prolonged in the Hypocapnia Group (P < 0.001).
Conclusion: In rats under sevoflurane anesthesia, prior hypocapnia delayed the onset of bupivacaine-induced
cardiotoxicity. Prior hypocapnia should be avoided during continuous bupivacaine nerve block under general
anesthesia, because it may delay the detection of cardiotoxicity.Introduction
Early signs and symptoms of local anesthetic toxicity in-
clude tinnitus, visual and auditory disturbances, restless-
ness, slurred speech, and muscle tremors (Strichartz and
Berde 2005). However, these symptoms are often masked
during general anesthesia and are typically noticed only
after the signs of cardiotoxicity occur, such as ventricular
premature beat (VPB) and/or hypotension. A recent
review of the literature studies on of local anesthetic
toxicity published over the past 30 years concluded that
decreased heart rate (HR) and mean arterial pressure
(MAP) may be represent important early signs of local
anesthetic toxicity, potentially occurring in half of all
cases (Di Gregorio et al. 2010).* Correspondence: toshiaki@hama-med.ac.jp
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in any medium, provided the original work is pMigration of the epidural catheter from the epidural
space into a blood vessel, e.g., an epidural vein, is rare,
but causes serious complications during continuous
epidural analgesia. Several large observational studies
reported incidences of migration of the epidural cath-
eter into a blood vessel of 0–0.67% and 0.25% (Wu and
Ouanes 2013; Pan et al. 2004). Accidental intravenous
local anesthetic infusion due to catheter migration can
cause sudden cardiovascular collapse (Wong et al. 2010;
Khan and Khadijah 2008). In such cases, hyperventilation
to induce hypocapnic alkalosis was proposed as a useful
maneuver to combat local anesthetic toxicity (Porter et al.
2000. Mechanical ventilation with high tidal volumes
(10 mL · kg−1–15 mL · kg−1 predicted body weight) has
historically been recommended to prevent hypoxemia
and atelectasis during general anesthesia (Bendixen et al.
1963; Kilpatrick and Slinger 2010); hence, some patients
may already be hypocapnic prior to accidental local
anesthetic exposure. However, it is unknown whetherpen Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
Table 1 Baseline body weight and hemodynamic
parameters
Control group (n =9) Hypocapnia group (n = 9)
Weight (g) 393 (13) 393 (15)
HR (bpm) 354 (32) 326 (20)
MAP (mmHg) 106 (20) 97 (18)
CVP (mmHg) 3.7 (1.1) 4.0 (0.6)
HR, heart rate; MAP, mean arterial pressure; CVP, central venous pressure.
Data are presented as means (±standard deviation).
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In this study, we examined whether prior hypocapnia
during general anesthesia delayed the onset of subsequent
bupivacaine-induced cardiotoxicity.
Methods
The experimental protocol was approved by the Institu-
tional Animal Care and Use Committee of the Hamamatsu
University School of Medicine (Hamamatsu, Japan; Permit
No. 2009033). Eighteen male Sprague–Dawley rats, weigh-
ing 370 g–425 g, were randomly divided into two groups
(n = 9 per group): those receiving sevoflurane alone
(Control Group) and those receiving sevoflurane with
hypocapnia (Hypocapnia Group). The trachea was
cannulated by tracheotomy following the induction of
sevoflurane anesthesia. Rats were placed on a ventilator
(Model 683; Harvard Bioscience Inc., Holliston, MA,
USA), and maintained at 50 breaths · min−1 and a frac-
tion of inspired oxygen of 1.0. Polyethylene catheters
(SP31; Natsume Co., Ltd., Tokyo, Japan) were placed in
the right femoral artery and vein to monitor the MAP and
for drug infusion, respectively. The left external jugular
vein was cannulated to monitor central venous pressure
(CVP) and for drug infusion. The effective dose for 50
percent of the group of sevoflurane in rats is 2.8%,
which corresponds to the minimum alveolar anesthetic
concentration determined using the tail-clamp technique
(Taheri et al. 1991). Therefore, anesthesia was maintained
with 2.8% inspired sevoflurane for the entire experimental
period.
Rats were allowed to stabilize for 20 min following sur-
gical preparation. The tidal volume was set at 6 mL · kg−1–
8 mL · kg−1 in the Control Group and 11 mL · kg−1–
12 mL · kg−1 in the Hypocapnia Group. Electrocardio-
grams, HR, MAP, and CVP were continuously recorded
(PowerLab; ADInstruments, Bella Vista, NSW, Australia).
Rectal temperature was maintained at 37°C–38°C through-
out the experimental period using a heating pad. After
30 min of hyperventilation in the Hypocapnia Group or
30 min of ventilation in the Control Group, both groups
were continuously infused with 0.25% bupivacaine at
2 mg · kg−1 · min−1 through the right femoral vein until
the conclusion of the study. Prior to the injection of
bupivacaine, arterial blood was sampled for blood gas
analysis.
The time taken to reach 25% and 50% reductions in
HR (HR-25%, HR-50%) and MAP (MAP-25%, MAP-50%)
from the start of bupivacaine infusion were measured after
the conclusion of the study. The difference between
HR-25%, and MAP-25% was calculated to estimate the
delay between the onset of HR decrease and myocardial
contractile depression. The times of the first VPB and
final systole were also measured after the conclusion of
the study.Statistical analysis
All values are expressed as means (±standard deviation
[SD]). The time required for HR and MAP to decline to
25% and 50% of their baseline values are expressed as
means (±SD). Means and mean differences were com-
pared by two-way between-subjects analysis of variance
(ANOVA). When the between-subjects ANOVA was
significant (P < 0.05), a post-hoc Tukey–Kramer test was
applied using Aabel 3 software (Hulinks Inc., Tokyo,
Japan).
Results
There were no significant differences in body weight, ini-
tial HR, initial MAP, or initial CVP between the groups
(Table 1). Only rats ventilated at a tidal volume of
11 mL · kg−1–12 mL · kg−1 (Hypocapnia Group) exhibited
hypocapnia (partial pressure of carbon dioxide [pCO2] =
30 [±3] mm Hg; Table 2).
The time from the onset of bupivacaine infusion to
HR-25% was not prolonged in the Hypocapnia Group
compared with the Control Group (305 [±137] s versus
298 [±171] s; P > 0.5). However, the time from onset of
bupivacaine infusion to HR-50% was prolonged in the
Hypocapnia Group compared with the Control Group
(1818 [±347] s versus 818 [±357] s; P < 0.001; Table 3).
The times required to reach MAP-25% and MAP-50%
were prolonged in the Hypocapnia Group compared
with the Control Group (MAP-25%: 1739 [±779] s ver-
sus 330 [±199] s; P < 0.001 and MAP-50%: 2319 [±440] s
versus 1111 [±431] s; P < 0.001; Table 3).
The Hypocapnia Group also demonstrated a longer
interval between HR-25% and MAP-25% compared with
the Control Group (1434 [±780] s versus 32 [±120] s;
P < 0.001; Figure 1). The times of the first VPB and final
systole were also prolonged in the Hypocapnia Group
compared with the Control Group (first VPB: 1938
[±318] s versus 848 [±310] s; P < 0.001 and time to final
systole: 2675 [±314] s versus 1593 [±250] s; P < 0.001;
Figure 2).
Discussion
Decreases in HR and MAP are important early signs of
local anesthetic toxicity in the myocardium (Di Gregorio
et al. 2010; Scott et al. 1989; Mauch et al. 2011), which
Table 2 Blood gas analysis and hemodynamic variables
before infusion of bupivacaine
Control group (n = 9) Hypocapnia group (n = 9)
pH 7.42 (0.02) 7.53 (0.02)*
pO2 (mmHg) 449 (87) 425 (63)
pCO2 (mmHg) 43 (5) 30 (3)*
HR (bpm) 342 (29) 319 (18)
MAP (mmHg) 110 (18) 108 (15)
CVP (mmHg) 4.3 (1.0) 4.4 (0.8)
HR, heart rate; MAP, mean arterial pressure; CVP, central venous pressure.
Data are presented as means (±standard deviation).
*P < 0.001 versus Control Group.
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arrhythmia (Di Gregorio et al. 2010). Thus, it is vital
that any inadvertent intravenous infusion of local
anesthetic, as can occur with catheter migration, be
recognized as early as possible. Our results demon-
strate that prior hypocapnia delayed these early signs of
bupivacaine-induced cardiotoxicity in rats under sevo-
flurane anesthesia. Although this delay suggests the
partial mitigation of cardiotoxicity due to hypocapnic
alkalosis, any delay in bradycardia or hypotension per-
mits an overall greater infusion of local anesthetic into
the circulation, ultimately exacerbating cardiotoxicity.
Thus, hypocapnia and associated alkalosis should be
avoided during procedures requiring general anesthesia
and local nerve blocks.
Hypocapnic alkalosis induced by hyperventilation may
reduce the cardiotoxicity induced by systemic local anes-
thetics (Porter et al. 2000; Englesson and Grevsten 1974).
Hypocapnia induced prior to intracoronary infusion of
ropivacaine in anesthetized dogs decreased the magnitude
of cardiotoxicity, implying that hypocapnic alkalosis may
be a useful adjunct (Porter et al. 2000). In addition, hypo-
capnia reversed the local anesthetic-induced suppression
of baroreflex sensitivity (Watanabe et al. 1997). In con-
trast, bupivacaine-induced cardiotoxicity was enhanced by
prior acidosis and hypercapnia (Englesson and Grevsten
1974; Rosen et al. 1985). Increased blood pH converts the
charged (channel-blocking) form of the local anesthetic toTable 3 The time and total doses of bupivacaine infused to re
start of bupivacaine infusion
Control group (n = 9) Time(s)
Total doses of bupivacaine infused (mg · kg−
Hypocapnia Group (n = 9) Time(s)
Total doses of bupivacaine infused (mg · kg−
HR-25%, HR-50%, MAP-25%, and MAP-50% are defined as the time taken to reach 2
from the start of bupivacaine infusion, respectively. Total doses of bupivacaine infu
MAP-50% were significantly prolonged in the Hypocapnia Group compared with th
the Hypocapnia Group than in the Control Group at HR-50%, MAP-25%, and MAP-5
*P < 0.001 versus Control Group.the uncharged form, which has a much lower channel af-
finity and diffuses into the cell more easily. Hypocapnia in-
creases intracellular pH, which decreases the intracellular
concentration of the active, charged form of the local
anesthetic (Strichartz and Berde 2005). This mechanism
may also explain the delayed bupivacaine-induced cardio-
toxicity following prior induction of hypocapnia.
The interval between HR-25% and MAP-25% was
markedly prolonged (44-fold) by prior hypocapnia. We
assume that this interval is equivalent to the time from
the onset of primary toxic symptoms until the start of
myocardial contractile depression. This delay permits
more bupivacaine to enter the circulation (in the sce-
nario of accidental infusion), making it more difficult to
treat patients with hypocapnia than those with normal
blood pCO2 and pH. Historically, mechanical ventilation
with high tidal volumes, i.e., >10 mL · kg−1, has been
recommended to prevent hypoxemia and atelectasis in
anesthetized patients (Bendixen et al. 1963). In contrast,
in current practice, lung protective strategies, including
mechanical ventilation with lower tidal volumes than
historic ventilation criteria, are recommended to minimize
barotrauma in the lung, which can cause acute respiratory
distress syndrome (Kilpatrick and Slinger 2010). Hyper-
ventilation by mechanical ventilation with high tidal vol-
umes may enhance the risk of local anesthetic toxicity. In
the Hypocapnia Group, the time to VPB was extended by
68%, and the time to asystole was extended by 128%, com-
pared with the Control Group. These relative delays were
considerably shorter than those between 25%-HR and
25%-MAP, possibly because the protocol was such that
the amount of local anesthetic administered was already
in the toxic range by the time MAP-25% was attained.
Hyperventilation by mechanical ventilation with high tidal
volumes should not be recommended in cases where
barotrauma of the lung must be minimized, or when
excessive infusion of local anesthetics into the circulation
has occurred following catheter migration into a blood
vessel.
We showed that hypocapnia under sevoflurane anesthesia
may be dangerous during the continuous infusion of localach HR-25%, HR-50%, MAP-25% and MAP-50% from the
HR-25 HR-50 MAP-25 MAP-50
298 (171) 818 (357) 330 (199) 1111 (431)
1) 9.9 (5.7) 27.3 (11.9) 11.0 (6.6) 37.1 (14.4)
305 (137) 1818 (347)* 1739 (779)* 2319 (440)*
1) 10.1 (4.6) 60.6 (11.5)* 58.0 (26.0)* 77.3 (14.7)*
5% and 50% reductions in heart rate (HR) and mean arterial pressure (MAP)
sed to reach each time point are also described. HR-50%, MAP-25%, and
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HR-25% and MAP-25%
Control Group Hypocapnia Group
Figure 1 The interval between HR-25% and MAP-25%. The interval between HR-25%, and MAP-25% was significantly prolonged in the
Hypocapnia Group compared with the Control Group. HR-25%, 25% reduction in heart rate; MAP-25%, 25% reduction in mean arterial pressure.
*P < 0.001 versus Control Group.
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ent toxicity due to catheter migration. However, this inves-
tigation is limited by the fact that all the experiments were
conducted under hyperoxic conditions. Future studies
must examine these effects under a range of oxygenation
conditions. Furthermore, we did not measure blood con-














Figure 2 Time to the first ventricular premature beat and to the final
final systole were prolonged in the Hypocapnia Group compared with the
Group. †P < 0.001 versus time to the final systole in the Control Group.HR-50%, MAP-25%, MAP-50%, time of the first VPB, and
time of the final systole were calculated after the conclu-
sion of the study, it was impossible to obtain blood sam-
ples at these time points.
Concerning the time taken for recovery from HR-50%
to the baseline HR after bupivacaine cessation, we expect




systole. The times to the first ventricular premature beat (VPB) and
Control Group. *P < 0.001 versus time to the first VPB in the Control
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our previous study (Mochizuki and Sato 2008). Similar
results are anticipated for the time required for recovery
from MAP-25% or MAP-50% to the baseline MAP.
Further study is necessary in this regard.
Aging degenerates the cardiac conduction systems,
accelerating the occurrence of ion channel dysfunction,
conduction delay, and arrhythmia (Park and Fishman
2011). In many studies on the systemic toxicity of local
anesthetics, the weight of the Sprague–Dawley rats used
ranged from approximately 300 g to 350 g. In this study,
the weight of the Sprague–Dawley rats used ranged from
370 g to 425 g. This means that the rats used in this
study were older than those weighing 300 g–350 g used
in similar studies. Therefore, the absolute values of
HR-25%, HR-50%, MAP-25%, MAP-50%, time of the
first VPB, and time of the final systole in this study
may have been influenced by aging compared with the
results of studies using younger rats. However, because
the effects of hypocapnia on local anesthetics are inde-
pendent of aging, we believe that the results of this
study are relevant to the use of local anesthetics in
clinical practice.
In conclusion, hypocapnia during general anesthesia
with sevoflurane delayed the onset of bupivacaine-
induced cardiovascular toxicity in rats. Despite this
protective effect, hypocapnia is not recommended dur-
ing continuous nerve blocking using local anesthetic
under general anesthesia, because it may facilitate a
greater infusion of toxins and, ultimately, cause greater
cardiovascular injury.
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